vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and Goosehead Insurance, Inc. (GSHD). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $93.1M, roughly 2.0× Goosehead Insurance, Inc.). Goosehead Insurance, Inc. runs the higher net margin — 8.6% vs 0.9%, a 7.7% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 23.1%). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 9.2%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Goosehead Insurance is a U.S.-based personal lines insurance agency that offers a wide range of coverage products including auto, home, renters, flood, and specialty insurance. It partners with hundreds of insurance carriers to provide clients with tailored, cost-effective coverage options, operating via corporate locations and a national franchise network for independent agents.
FOLD vs GSHD — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $93.1M |
| Net Profit | $1.7M | $8.0M |
| Gross Margin | 85.7% | — |
| Operating Margin | 8.6% | 16.1% |
| Net Margin | 0.9% | 8.6% |
| Revenue YoY | 23.7% | 23.1% |
| Net Profit YoY | -88.5% | 204.0% |
| EPS (diluted) | $0.00 | $0.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $93.1M | ||
| Q4 25 | $185.2M | $105.3M | ||
| Q3 25 | $169.1M | $90.4M | ||
| Q2 25 | $154.7M | $94.0M | ||
| Q1 25 | $125.2M | $75.6M | ||
| Q4 24 | $149.7M | $93.9M | ||
| Q3 24 | $141.5M | $78.0M | ||
| Q2 24 | $126.7M | $78.1M |
| Q1 26 | — | $8.0M | ||
| Q4 25 | $1.7M | $12.4M | ||
| Q3 25 | $17.3M | $7.9M | ||
| Q2 25 | $-24.4M | $5.2M | ||
| Q1 25 | $-21.7M | $2.3M | ||
| Q4 24 | $14.7M | $14.9M | ||
| Q3 24 | $-6.7M | $7.6M | ||
| Q2 24 | $-15.7M | $6.2M |
| Q1 26 | — | — | ||
| Q4 25 | 85.7% | — | ||
| Q3 25 | 88.5% | — | ||
| Q2 25 | 90.2% | — | ||
| Q1 25 | 90.7% | — | ||
| Q4 24 | 90.1% | — | ||
| Q3 24 | 90.6% | — | ||
| Q2 24 | 91.1% | — |
| Q1 26 | — | 16.1% | ||
| Q4 25 | 8.6% | 29.4% | ||
| Q3 25 | 20.3% | 23.5% | ||
| Q2 25 | -6.1% | 16.7% | ||
| Q1 25 | -6.3% | 8.8% | ||
| Q4 24 | 10.7% | 29.7% | ||
| Q3 24 | 15.3% | 21.1% | ||
| Q2 24 | 11.8% | 19.7% |
| Q1 26 | — | 8.6% | ||
| Q4 25 | 0.9% | 11.8% | ||
| Q3 25 | 10.2% | 8.7% | ||
| Q2 25 | -15.8% | 5.5% | ||
| Q1 25 | -17.3% | 3.1% | ||
| Q4 24 | 9.8% | 15.8% | ||
| Q3 24 | -4.8% | 9.7% | ||
| Q2 24 | -12.4% | 7.9% |
| Q1 26 | — | $0.19 | ||
| Q4 25 | $0.00 | $0.48 | ||
| Q3 25 | $0.06 | $0.29 | ||
| Q2 25 | $-0.08 | $0.18 | ||
| Q1 25 | $-0.07 | $0.09 | ||
| Q4 24 | $0.05 | $0.58 | ||
| Q3 24 | $-0.02 | $0.29 | ||
| Q2 24 | $-0.05 | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $25.7M |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | $-121.3M |
| Total Assets | $949.9M | $392.8M |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $25.7M | ||
| Q4 25 | $293.5M | $34.4M | ||
| Q3 25 | $263.8M | $51.6M | ||
| Q2 25 | $231.0M | $92.4M | ||
| Q1 25 | $250.6M | $70.2M | ||
| Q4 24 | $249.9M | $54.3M | ||
| Q3 24 | $249.8M | $47.5M | ||
| Q2 24 | $260.1M | $23.6M |
| Q1 26 | — | — | ||
| Q4 25 | $392.7M | $289.5M | ||
| Q3 25 | $392.0M | $290.0M | ||
| Q2 25 | $391.3M | $289.8M | ||
| Q1 25 | $390.7M | $290.3M | ||
| Q4 24 | $390.1M | $82.3M | ||
| Q3 24 | $389.5M | $84.6M | ||
| Q2 24 | $388.9M | $87.0M |
| Q1 26 | — | $-121.3M | ||
| Q4 25 | $274.2M | $-95.5M | ||
| Q3 25 | $230.4M | $-105.0M | ||
| Q2 25 | $204.3M | $-78.6M | ||
| Q1 25 | $193.6M | $-88.5M | ||
| Q4 24 | $194.0M | $43.9M | ||
| Q3 24 | $178.8M | $58.3M | ||
| Q2 24 | $132.5M | $39.8M |
| Q1 26 | — | $392.8M | ||
| Q4 25 | $949.9M | $414.9M | ||
| Q3 25 | $868.8M | $403.6M | ||
| Q2 25 | $815.3M | $436.6M | ||
| Q1 25 | $789.8M | $412.6M | ||
| Q4 24 | $785.0M | $397.7M | ||
| Q3 24 | $786.6M | $358.1M | ||
| Q2 24 | $749.5M | $338.2M |
| Q1 26 | — | — | ||
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | 1.87× | ||
| Q3 24 | 2.18× | 1.45× | ||
| Q2 24 | 2.93× | 2.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | — |
| Free Cash FlowOCF − Capex | $16.0M | — |
| FCF MarginFCF / Revenue | 8.6% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | 9.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $16.3M | $91.8M | ||
| Q3 25 | $35.7M | $24.2M | ||
| Q2 25 | $-26.5M | $28.9M | ||
| Q1 25 | $7.8M | $15.5M | ||
| Q4 24 | $-3.9M | $71.5M | ||
| Q3 24 | $-23.0M | $28.1M | ||
| Q2 24 | $22.7M | $18.9M |
| Q1 26 | — | — | ||
| Q4 25 | $16.0M | $86.1M | ||
| Q3 25 | $35.3M | $23.7M | ||
| Q2 25 | $-28.9M | $27.2M | ||
| Q1 25 | $7.5M | $14.9M | ||
| Q4 24 | $-4.2M | $70.6M | ||
| Q3 24 | $-23.3M | $28.0M | ||
| Q2 24 | $21.6M | $18.6M |
| Q1 26 | — | — | ||
| Q4 25 | 8.6% | 81.8% | ||
| Q3 25 | 20.9% | 26.2% | ||
| Q2 25 | -18.7% | 28.9% | ||
| Q1 25 | 6.0% | 19.7% | ||
| Q4 24 | -2.8% | 75.1% | ||
| Q3 24 | -16.5% | 35.9% | ||
| Q2 24 | 17.0% | 23.9% |
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | 5.4% | ||
| Q3 25 | 0.2% | 0.5% | ||
| Q2 25 | 1.6% | 1.8% | ||
| Q1 25 | 0.2% | 0.8% | ||
| Q4 24 | 0.2% | 1.0% | ||
| Q3 24 | 0.3% | 0.1% | ||
| Q2 24 | 0.9% | 0.3% |
| Q1 26 | — | — | ||
| Q4 25 | 9.62× | 7.38× | ||
| Q3 25 | 2.06× | 3.06× | ||
| Q2 25 | — | 5.61× | ||
| Q1 25 | — | 6.61× | ||
| Q4 24 | -0.27× | 4.82× | ||
| Q3 24 | — | 3.72× | ||
| Q2 24 | — | 3.05× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
GSHD
| Renewal Royalty Fees (2) | $43.6M | 47% |
| Renewal Commissions (1) | $18.2M | 20% |
| Contingent Commissions (1) | $10.7M | 11% |
| New Business Royalty Fees (2) | $7.9M | 8% |
| New Business Commissions (1) | $7.5M | 8% |
| Other | $3.7M | 4% |
| Initial Franchise Fees (2) | $1.6M | 2% |
